sglt2 or glp 1 inhibitors and GLP-1 receptor agonists: a sound combination SGLT-2 Inhibitors and GLP-1 Agonists:

The NYPD is now investigating the sudden death of beloved Food Network star Anne Burrell as a possible drug overdose.

PlexusDx explains what to expect, how to prevent complications, and when to contact your care team

A retrospective analysis of 105,000+ patients revealed: 40% lower OSA risk with tirzepatide (Zepbound) or semaglutide (Wegovy) vs non-AOM users Lower OSA incidence: 3.12% vs 12.56% Comparable impact between tirzepatide and semaglutide, with tirzepatide showing a slight edge after 6 months This study highlights the potential for AOMs to address obesity and OSA, supporting broader healthcare value through comorbidity reduction

Additionally, these agents may mitigate cardiovascular risks and improve outcomes in patients with conditions like polycystic ovary syndrome (PCOS)

Discover the side effects of GLP-1 medications and learn how to manage them